AVIR
Atea Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.33
+1.33%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.51
- Revenue estimate
- $50.4M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$0.56
- Revenue actual
- —
- Revenue estimate
- $33.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -0.4%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.56 | -$0.41 | Beat 26.13% | — |
| May 12, 2026 | -$0.60 | -$0.57 | Beat 5.00% | — |
| Mar 5, 2026 | -$0.48 | -$0.57 | Miss -17.53% | — |
| Nov 12, 2025 | -$0.46 | -$0.53 | Miss -15.22% | — |
| Aug 7, 2025 | -$0.46 | -$0.44 | Beat 4.35% | — |
| Mar 6, 2025 | -$0.35 | -$0.40 | Miss -14.29% | — |
| Nov 7, 2024 | -$0.50 | -$0.37 | Beat 26.00% | — |
| Feb 28, 2024 | -$0.44 | -$0.47 | Miss -6.82% | — |
| Feb 28, 2023 | -$0.45 | -$0.41 | Beat 8.89% | — |
| Feb 28, 2022 | $0.17 | $1.34 | Beat 688.24% | $192.2M |
| Nov 11, 2021 | -$0.05 | -$0.34 | Miss -580.00% | $32.8M |
| Aug 12, 2021 | $0.01 | $0.02 | Beat 300.00% | $60.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026